Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Portfolio Review on Birth Defects and Developmental Disabilities, 63017 [E6-18005]
Download as PDF
<![CDATA[
63017
Federal Register / Vol. 71, No. 208 / Friday, October 27, 2006 / Notices
services; and adherence to drug
regimens. Collection of data from
patient medical records will provide
information on: Demographics and
insurance status; the prevalence and
incidence of AIDS-defining
opportunistic illnesses and comorbidities related to HIV disease; the
receipt of prophylactic and
antiretroviral medications; and whether
patients are receiving screening and
treatment according to Public Health
Service guidelines. No other Federal
agency collects national populationbased behavioral and clinical
information from HIV-infected adults in
care. The data will have significant
implications for policy, program
development, and resource allocation at
the State/local and national levels.
CDC is requesting approval for a 3year clearance for data collection. Data
will be collected by 26 Reporting Areas
(19 States, Puerto Rico and 6 separately
funded cities). CDC estimates an average
of 400 respondents per site with an 80%
response rate, resulting in 8,320
respondents for the interview portion. A
Short interview will be used for patients
who are too ill to complete the Standard
interview or when the interview must
be translated, and a Proxy interview will
be available if the patient consents to
having a family member or other person
answer the questions in the case of
severe illness or in the event the
selected participant died prior to being
interviewed. The proxy and the short
interview, each which will be used on
approximately 2% of patients, will take
approximately 20 minutes. Participation
of respondents is voluntary and there is
no cost to the respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Types of data collection
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Standard interview ...................................................................................................
Short interview .........................................................................................................
Proxy interview ........................................................................................................
7,988
166
166
1
1
1
45/60
20/60
20/60
5,991
55
55
Total ..................................................................................................................
........................
........................
........................
6,101
Dated: October 23, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–18014 Filed 10–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Portfolio Review on
Birth Defects and Developmental
Disabilities
jlentini on PROD1PC65 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel: Portfolio Review on Birth Defects and
Developmental Disabilities.
Times and Dates:
8:30 a.m.–4:30 p.m., January 8, 2007
(Closed).
8 a.m.–5 p.m., January 9, 2007 (Closed).
Place: CDC Harkin Global Communications
Center, 1600 Clifton Road, Atlanta, GA
30333.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
VerDate Aug<31>2005
16:53 Oct 26, 2006
Jkt 211001
Matters To Be Discussed: The meeting will
include the review of the Division of Birth
Defects and Developmental Disabilities’
programs, strategies, and activities.
Contact Person for More Information:
Esther Sumartojo, Associate Director for
Science, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600
Clifton Road, NE., Mailstop E–87, Atlanta,
GA 30333, Telephone Number 404.498.3072.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 20, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–18005 Filed 10–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Program Peer Review
Subcommittee of the Board of Scientific
Counselors (BSC), Centers for Disease
Control and Prevention (CDC), National
Center for Environmental Health/
Agency for Toxic Substances and
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Disease Registry (NCEH/ATSDR):
Teleconference.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC, NCEH/ATSDR
announces the following subcommittee
meeting:
Name: Program Peer Review Subcommittee
(PPRS).
Time and Date: 8:30 a.m.–10:30 a.m.
Eastern Standard Time, November 22, 2006.
Place: The teleconference will originate at
NCEH/ATSDR in Atlanta, Georgia. To
participate, dial 877/315–6535 and enter
conference code 383520.
Purpose: Under the charge of the BSC,
NCEH/ATSDR, the PPRS will provide the
BSC, NCEH/ATSDR with advice and
recommendations on NCEH/ATSDR program
peer review. They will serve the function of
organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/
ATSDR program peer review.
Matters To Be Discussed: A review of the
previous meeting; an update on the planning
of the Site Specific Activities Peer Review; a
discussion of the revised Peer Review
Conflict-of-Interest form; a discussion of
Terrorism Preparedness and Emergency
Response Peer Review in February 2007:
Divisions included in the review, areas of
expertise required for the review, and
nominations for a PPRS panel member,
chairperson and peer reviewers.
Agenda items are subject to change as
priorities dictate.
This
meeting is scheduled to begin at 8:30
a.m. Eastern Standard Time. To
participate, please dial 877/315–6535
and enter conference code 383520.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 71, Number 208 (Friday, October 27, 2006)]
[Notices]
[Page 63017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18005]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Portfolio Review on Birth Defects and Developmental
Disabilities
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel: Portfolio Review on Birth Defects and
Developmental Disabilities.
Times and Dates:
8:30 a.m.-4:30 p.m., January 8, 2007 (Closed).
8 a.m.-5 p.m., January 9, 2007 (Closed).
Place: CDC Harkin Global Communications Center, 1600 Clifton
Road, Atlanta, GA 30333.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review of
the Division of Birth Defects and Developmental Disabilities'
programs, strategies, and activities.
Contact Person for More Information: Esther Sumartojo, Associate
Director for Science, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600 Clifton Road, NE., Mailstop E-
87, Atlanta, GA 30333, Telephone Number 404.498.3072.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: October 20, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-18005 Filed 10-26-06; 8:45 am]
BILLING CODE 4163-18-P
